![](/img/cover-not-exists.png)
[Lupus Foundation of America 12th European Lupus Meeting - ()] Poster presentations - P130â Treatment of SLE with the immunoproteasome inhibitor KZR-616: results from the first 4 cohorts of the MISSION study, an open-label phase 1b dose escalation trial
Furie, Richard, Parikh, Samir V, Maiquez, Adonis, Khan, Amber, Moreno, Orlando, Soneira, Miguel, Kirk, Christopher, Bomba, Darrin, Harvey, Kenneth, Farmer, Mary KatherineDOI:
10.1136/lupus-2020-eurolupus.174
File:
PDF, 69 KB